Thursday, May 25th | 29 Iyyar 5777

Close

Be in the know!

Get our exclusive daily news briefing.

Subscribe
February 5, 2015 11:55 am

Jewish 100, 2014: Ephrat Levy-Lahad – Innovation and Activism

avatar by Algemeiner Staff

Email a copy of "Jewish 100, 2014: Ephrat Levy-Lahad – Innovation and Activism" to a friend

Ephrat Levy-Lahad. Photo: Breast Cancer Research Foundation.

Ephrat Levy-Lahad

Medical researcher

All women of Ashkenazi origin should be screened for two breast-cancer predisposition genes from the age of 30, said Prof. Ephrat Levy-Lahad, the head of a leading research team at Shaare Zedek Medical Center. Levy-Lahad’s 2014 announcement, which received international attention, was a departure from the previous guideline of testing for the two BRCA genes only if a close blood relative contracted breast or ovarian cancer. The finding will likely change screening practices in Israel and in Jewish communities worldwide, ultimately saving lives.

Share this Story: Share On Facebook Share On Twitter Email This Article

Let your voice be heard!

Join the Algemeiner

Algemeiner.com